We further evaluate whether the positive frequency of autoantibody to SPP1 had significant differences in different clinical subgroups from ESCC (age, sex, smoking, drinking, lymphatic metastasis, TNM stage, distance metastasis, differentiation, family tumor history). This evidence concerns the gene SPP1 and esophageal squamous cell carcinoma.